HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
January 14, 2025
Host Jonathan Miller interviews CFO: Jason Keyes, who's committed to harnessing the power of the immune system by using Equillium's services, to transform patient care.